A Single Dose Trial of Recombinant Factor VIII (N8) in Japanese Subjects With Haemophilia A: An Extension to Trial NN7008-3543

Inclusion Criteria: * Japanese subjects who have completed NN7008-3543 * No detectable inhibitors to factor VIII Exclusion Criteria: * Congenital or acquired coagulation disorders other than haemophilia A * Planned surgery during the trial period * Receipt of any investigational drug other than recombinant factor VIII (N8) within 30 days of trial product administration